115. Miscarriage & Recurrent Pregnancy Loss: A Thoughtful, Cycle-Informed Evaluation

What if the most important step after pregnancy loss isn’t “try again,” but being truly seen and given a thoughtful plan? In this special episode for Pregnancy & Infant Loss Awareness Month, Dr. Monica Minjeur shares how restorative reproductive medicine supports women with cycle-informed evaluation, timed hormone labs, thyroid and insulin testing, male factor assessment, and screening for chronic endometritis—often missed in standard care. With compassion and clarity, discover how to build a plan that honors your grief while restoring your body’s ability to heal and conceive.Key TakeawaysCompassion first: Honor grief, name the baby if desired, and move at your own pace.Cycle-informed evaluation: Use charting to assess ovulation return, luteal phase strength, fertile signs, and bleeding patterns (especially brown bleeding).Timed hormone labs: Check progesterone and estradiol ~7 days after ovulation to assess ovulation quality—not just “day 21” labs.Thyroid & insulin matter: Full thyroid panel (TSH, Free T4, Free/Total T3, antibodies) and insulin testing (fasting or OGTT with insulin).Screen for chronic endometritis: Especially if there’s brown bleeding, early loss, or heavy cycles. Consider menstrual testing, biopsy, or hysteroscopy.Male factor is essential: Include semen analysis and DNA fragmentation testing, even if conception occurred.Re-testing is critical: Confirm improvements after treatment—labs, charting, and symptom resolution all guide timing.When to try again: A shared decision—emotionally ready, physically supported, with a clear plan for early pregnancy monitoring (HCG, progesterone, estradiol).If you’ve experienced pregnancy loss and feel like you’re navigating it alone or without answers, we’re here to help. At Radiant Clinic, we combine compassionate care with cycle-informed, restorative evaluation to create a plan designed for your body and your story. Schedule your free discovery call at radiantclinic.com

There are no comments yet.

Please log in to write the first comment.